Patient safety is the most important value for the Gedeon Richter Group. Thus monitoring adverse drug events occurring during pharmacotherapy is especially important for us. We offer to
Przechowywać w opakowaniu w celu ochrony przed światłem °C
According to the World Health Organisation, heart and circulatory diseases are the most common causes of deaths in developed countries, while arterial hypertension – which is an extremely dangerous and chronic disease – is the most common condition affecting the circulatory system.
Many women consider gynaecological issues – those involving...
Despite universal media access and numerous health-promoting preventive...
This section contains information intended solely for doctors, pharmacists and other persons authorised to receive specialty medical information.
If you are a doctor, pharmacist or are otherwise authorised to receive specialty medical information continue to the next page.
W przeciwnym razie, zapraszamy do zapoznania się z pozostałą częścią naszego serwisu powrót do strony głównej
We are all looking forward to new, excellent medicines and even more effective therapies. Sometimes, it takes a long time before the drug will be released to the market. It usually starts with the idea of a new product, a long period of research, testing, and the production and distribution of the new medicine.